Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study

View source ↗

Summary

A post-approval, recruiting study evaluating the Inspire UAS device for obstructive sleep apnea in patients with high apnea–hypopnea index or high BMI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inspire UAS

Snippet

Sponsor: Inspire Medical Systems, Inc. | Conditions: Obstructive Sleep Apnea (OSA) | Status: RECRUITING